Dedicated to helping eliminate the global threat of antimicrobial resistance, the David Braley Centre for Antibiotic Discovery (DBCAD) has demonstrated its commitment to fostering scientific collaboration by providing significant seed funding for four milestone-driven projects related to antimicrobial research and discovery.
The purpose of these funding initiatives is to provide support for trainees and operating funds to help investigators generate preliminary data that will enable them to seek additional funding from other agencies and further amplify the impact of their research.
Following an external review of submitted research proposals, the DBCAD is pleased to announce this year’s recipients:
